SONIA GARCIA: Open Payments
NPI 1992046296 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 37 payments from 9 companies in 2025. Trend: 2023 $1,490 · 2024 $934 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 12 | $328 |
| Vanda Pharmaceuticals Inc. | 9 | $236 |
| Otsuka America Pharmaceutical, Inc. | 4 | $124 |
| ABBVIE INC. | 5 | $103 |
| Alkermes, Inc. | 3 | $75 |
| Alpha Cognition USA, Inc. | 1 | $48 |
| Lilly USA, LLC | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: NUPLAZID, FANAPT, REXULTI, VRAYLAR, ARISTADA, Zunveyl, ZEPBOUND, INGREZZA.
Industry payments across CA — which companies pay providers there.
